Dashboard
Manage Tickers

INO INOVIO PHARMACEUTICALS, INC.

Nasdaq inovio.com


$ 2.40 $ -0.07 (-2.88 %)    

Thursday, 30-Oct-2025 17:06:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 633.20 nm (nm)
DIA $ 475.83 $ -1.36 (-0.29 %)
SPY $ 684.43 nm (nm)
TLT $ 90.42 nm (nm)
GLD $ 371.67 nm (nm)
$ 2.36
$ 2.46
$ 2.34 x 1,000
$ 2.50 x 90
$ 2.36 - $ 2.47
$ 1.30 - $ 5.80
801,497
na
125.42M
$ 1.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-18-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-06-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-01-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-12-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-12-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 03-14-2018 12-31-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-15-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-08-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 03-14-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

inovio-announces-publication-of-results-from-phase-1-proof-of-concept-trial-evaluating-dmabs-for-covid-19
INOVIO Announces Publication Of Results Fr...
10/21/2025 12:09:13

inovio-on-track-to-complete-ino-3107-biologics-license-application-by-2h25-targets-fda-acceptance-by-year-end
INOVIO On Track To Complete INO-3107 Biolo...
08/26/2025 12:09:51

Complete submission of the Biologics License Application (BLA) remains on track for 2H25 with the goal of file acceptance by U....

hc-wainwright--co-reiterates-neutral-on-inovio-pharmaceuticals-maintains-3-price-target
HC Wainwright & Co. Reiterates Neutral on ...
08/14/2025 11:29:58

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Neutral and maintai...

inovio-pharmaceuticals-q2-eps-061-beats-062-estimate
Inovio Pharmaceuticals Q2 EPS $(0.61) Beat...
08/12/2025 20:05:56

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

earnings-outlook-for-inovio-pharmaceuticals
Earnings Outlook For Inovio Pharmaceuticals
08/11/2025 18:02:16

inovios-announces-peer-reviewed-data-from-a-retrospective-study-investigating-the-long-term-clinical-and-safety-response-of-patients-treated-with-ino-3107-were-published-online-in-the-laryngoscope-ino-3107-shows-sustained-improvement-in-rrp-patients-cutting-surgeries-by-over-75-in-year-2
INOVIO's Announces Peer-reviewed Data From...
08/11/2025 12:09:36

Retrospective trial showed Overall Response Rate (ORR) improved to 86% at the end of the second 12-month period (Year 2) compar...

this-wingstop-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Wingstop Analyst Begins Coverage On A...
07/09/2025 14:13:46

piper-sandler-initiates-coverage-on-inovio-pharmaceuticals-with-overweight-rating-announces-price-target-of-5
Piper Sandler Initiates Coverage On Inovio...
07/09/2025 12:24:59

Piper Sandler initiates coverage on Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight rating and announces Price Target o...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/03/2025 21:05:44

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/03/2025 17:07:08

crude-oil-down-1-tripadvisor-shares-jump
Crude Oil Down 1%; Tripadvisor Shares Jump
07/03/2025 16:31:55

dow-jumps-over-200-points-us-nonfarm-payrolls-beat-estimates
Dow Jumps Over 200 Points; US Nonfarm Payr...
07/03/2025 14:08:15

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/03/2025 12:07:47

inovio-prices-offering-of-14285715-shares-and-accompanying-warrants-at-combined-offering-price-of-175share-gross-proceeds-25m
INOVIO Prices Offering Of 14,285,715 Share...
07/03/2025 11:32:23

why-datadog-shares-are-trading-higher-by-over-10-here-are-20-stocks-moving-premarket
Why Datadog Shares Are Trading Higher By O...
07/03/2025 09:44:37

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/02/2025 21:05:48

inovio-announces-proposed-public-offering-size-not-disclosed
INOVIO Announces Proposed Public Offering,...
07/02/2025 20:16:35

avacta-appoints-dr-david-liebowitz-as-chief-medical-officer-to-lead-cancer-drug-strategy
Avacta Appoints Dr. David Liebowitz as Chi...
07/01/2025 11:04:43

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announces the appoi...

Core News & Articles
World Health Organization Says MPOX Remain...
06/09/2025 14:22:11

https://www.who.int/news/item/09-06-2025-fourth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-rega...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION